Alignment Healthcare (NASDAQ:ALHC) Earns “Outperform” Rating from William Blair

Alignment Healthcare (NASDAQ:ALHC)‘s stock had its “outperform” rating restated by research analysts at William Blair in a research report issued on Friday,RTT News reports.

Several other analysts also recently issued reports on ALHC. Stephens reaffirmed an “overweight” rating and issued a $17.00 price objective on shares of Alignment Healthcare in a research report on Monday. Barclays raised their price target on shares of Alignment Healthcare from $8.00 to $9.00 and gave the company an “underweight” rating in a report on Friday. Finally, Stifel Nicolaus upped their price objective on shares of Alignment Healthcare from $14.00 to $16.00 and gave the company a “buy” rating in a research report on Tuesday, January 14th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $12.25.

Alignment Healthcare Stock Up 15.9 %

Shares of ALHC stock traded up $2.14 during trading hours on Friday, reaching $15.61. The company had a trading volume of 1,817,266 shares, compared to its average volume of 1,865,031. The company has a market capitalization of $2.99 billion, a P/E ratio of -20.18 and a beta of 1.50. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60. Alignment Healthcare has a twelve month low of $4.46 and a twelve month high of $15.85. The stock’s fifty day simple moving average is $13.40 and its 200 day simple moving average is $11.89.

Insider Transactions at Alignment Healthcare

In related news, COO Sebastian Burzacchi sold 8,550 shares of the company’s stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $11.26, for a total transaction of $96,273.00. Following the sale, the chief operating officer now directly owns 217,395 shares of the company’s stock, valued at approximately $2,447,867.70. This represents a 3.78 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, President Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $13.72, for a total transaction of $411,600.00. Following the completion of the transaction, the president now directly owns 1,576,097 shares of the company’s stock, valued at approximately $21,624,050.84. This represents a 1.87 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 441,002 shares of company stock valued at $5,772,726. Insiders own 6.60% of the company’s stock.

Institutional Trading of Alignment Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of ALHC. Creative Planning grew its position in shares of Alignment Healthcare by 20.0% during the 3rd quarter. Creative Planning now owns 12,442 shares of the company’s stock valued at $147,000 after buying an additional 2,072 shares during the last quarter. Principal Financial Group Inc. boosted its stake in Alignment Healthcare by 1,335.1% in the third quarter. Principal Financial Group Inc. now owns 194,043 shares of the company’s stock valued at $2,294,000 after acquiring an additional 180,522 shares during the period. Royce & Associates LP acquired a new position in Alignment Healthcare in the third quarter valued at approximately $3,782,000. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Alignment Healthcare during the third quarter valued at approximately $131,000. Finally, Intech Investment Management LLC acquired a new stake in shares of Alignment Healthcare during the 3rd quarter worth approximately $315,000. 86.19% of the stock is owned by institutional investors and hedge funds.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.